Alkermes Plc (ALKS)
41.75
+1.21
(+2.98%)
USD |
NASDAQ |
Oct 02, 16:00
41.76
0.00 (0.00%)
After-Hours: 20:00
Alkermes Market Cap : 6.995B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.995B |
| October 01, 2026 | 6.792B |
| September 30, 2026 | 6.789B |
| September 29, 2026 | 6.836B |
| September 28, 2026 | 6.727B |
| September 25, 2026 | 6.844B |
| September 24, 2026 | 6.834B |
| September 23, 2026 | 7.059B |
| September 22, 2026 | 7.253B |
| September 21, 2026 | 7.402B |
| September 18, 2026 | 7.270B |
| September 17, 2026 | 7.826B |
| September 16, 2026 | 7.719B |
| September 15, 2026 | 7.712B |
| September 14, 2026 | 7.678B |
| September 11, 2026 | 7.702B |
| September 10, 2026 | 7.725B |
| September 09, 2026 | 7.606B |
| September 08, 2026 | 7.621B |
| September 04, 2026 | 7.724B |
| September 03, 2026 | 7.854B |
| September 02, 2026 | 7.995B |
| September 01, 2026 | 7.908B |
| August 31, 2026 | 7.873B |
| August 28, 2026 | 7.943B |
| Date | Value |
|---|---|
| August 27, 2026 | 8.193B |
| August 26, 2026 | 8.236B |
| August 25, 2026 | 8.245B |
| August 24, 2026 | 8.188B |
| August 21, 2026 | 8.097B |
| August 20, 2026 | 8.045B |
| August 19, 2026 | 8.407B |
| August 18, 2026 | 8.290B |
| August 17, 2026 | 8.352B |
| August 14, 2026 | 8.220B |
| August 13, 2026 | 8.285B |
| August 12, 2026 | 8.424B |
| August 11, 2026 | 8.245B |
| August 10, 2026 | 8.277B |
| August 07, 2026 | 8.238B |
| August 06, 2026 | 8.104B |
| August 05, 2026 | 8.312B |
| August 04, 2026 | 8.322B |
| August 03, 2026 | 8.298B |
| July 31, 2026 | 8.208B |
| July 30, 2026 | 8.382B |
| July 29, 2026 | 8.099B |
| July 28, 2026 | 8.461B |
| July 27, 2026 | 8.834B |
| July 24, 2026 | 8.861B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 259.38M |
| Prothena Corp. Plc | 432.58M |
| Biogen, Inc. | 32.48B |
| Exelixis, Inc. | 14.53B |
| Incyte Corp. | 23.17B |
Market Cap Related Metrics
| PE Ratio | 108.44 |
| PS Ratio | 4.242 |
| Price to Book Value | 3.868 |
| Price to Free Cash Flow | 31.91 |
| Price | 41.75 |
| Earnings Yield | 0.92% |
| Operating PE Ratio | 49.24 |
| Normalized PE Ratio | 84.93 |